Correlates of circulating osteoprotegerin in women with a pathogenic or likely pathogenic variant in the BRCA1 gene.
Sarah S ParkTasnim ZamanShana J KimJennifer D BrooksAndy Kin On WongJan A LubińskiSteven A NarodLeonardo SalmenaJoanne KotsopoulosPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
These findings suggest that circulating OPG levels are not impacted by non-genetic factors in high-risk women.